[{"Assets_0_Q3_USD":66657000.0,"CommonStockSharesOutstanding_0_Q3_shares":10792646.0,"NetIncomeLoss_1_Q3_USD":-5234000.0,"NetIncomeLoss_3_Q3_USD":-15148000.0,"StockholdersEquity_0_Q3_USD":28568000.0,"Ticker":"KALV","CIK":"1348911","name":"KALVISTA PHARMACEUTICALS, INC.","OfficialName":"KalVista Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180131","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"339433230.0","Country":"United Kingdom","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180316"}]